Ingrid C. Verhaart
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Challenges of Assessing Exon 53 Skipping of the Human DMD Transcript with Locked Nucleic Acid-Modified Antisense Oligonucleotides in a Mouse Model for Duchenne Muscular Dystrophy.
Journal: Nucleic acid therapeutics
Published: November 27, 2023
Author's Response to: Rebuttal to: Simvastatin Treatment Does Not Ameliorate Muscle Pathophysiology in a Mouse Model for Duchenne Muscular Dystrophy, Verhaart et al. 2020.
Journal: Journal of neuromuscular diseases
Published: September 20, 2021
7',5'-alpha-bicyclo-DNA: new chemistry for oligonucleotide exon splicing modulation therapy.
Journal: Nucleic acids research
Published: December 11, 2020
Simvastatin Treatment Does Not Ameliorate Muscle Pathophysiology in a Mouse Model for Duchenne Muscular Dystrophy.
Journal: Journal of neuromuscular diseases
Published: October 12, 2020
Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks.
Journal: Pharmacological research
Published: April 10, 2020
Meeting on data sharing for Duchenne 21-22 March 2019 Amsterdam, the Netherlands.
Journal: Neuromuscular disorders : NMD
Published: August 13, 2019
Therapeutic developments for Duchenne muscular dystrophy.
Journal: Nature reviews. Neurology
Published: May 31, 2019
Muscle biopsies in clinical trials for Duchenne muscular dystrophy - Patients' and caregivers' perspective.
Journal: Neuromuscular disorders : NMD
Published: April 05, 2019
Nutrition in Duchenne muscular dystrophy 16-18 March 2018, Zaandam, the Netherlands.
Journal: Neuromuscular disorders : NMD
Published: April 26, 2018
Last Updated: 09/26/2026